Dr. Janet Ngoclan Chu, MD, MPH

Dr. Chu practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Chu's NPI, 1225482482, was assigned on April 14, 2016. Dr. Chu graduated from UCSF School of Medicine in 2015. Dr. Chu holds California license A155736.

Dr. Chu's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Chu's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Chu to 5 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chu practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chu is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chu is licensed in California.

Dmand AI lists acute kidney failure, asthma, atrial fibrillation and flutter, bladder disease, chronic diabetes, chronic hypertension, chronic obstructive pulmonary disease (COPD) and cold sores or genital herpes among the conditions Dr. Chu treats.

CMS data shows 311 Medicare services from Dr. Chu across 4 procedure codes in 2024, for 139 Medicare patients. Medicare paid $16,126 for them. Every service was in an office.

CMS counts 139 Medicare patients who saw Dr. Chu in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chu's median patient age at 67, with 56% women.

In 2024, Dr. Chu wrote 1,399 Medicare Part D claims for 158 patients. 81% of them were for generic drugs. CMS names the drug for 988 of them, across 44 drugs with 11 or more claims each, at $133,863 in total drug cost. In 2023, CMS named 424 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Chu for performance year 2024, reported as part of a group. Dr. Chu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chu as offering telehealth.

Dmand AI links 23 papers to Dr. Chu, published from 2015 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Asian, California and COVID-19. Dr. Chu has published most often in Am J Med. Dr. Chu's most frequent co-authors are Janice Y. Tsoh, MD, Danielle Brandman, MAS, MD and Rena K. Fox, MD.

CMS Open Payments shows 1 general payment to Dr. Chu from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $47.

Dr. Chu graduated from UCSF School of Medicine in 2015.

Dr. Chu is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.